Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06993688 · ClinicalTrials.gov registry record · NA

Revealing Information Genuinely & Honestly Across Time - Communication Preferences Visit

A NA study of Cancer and Communication, sponsored by St. Jude Children's Research Hospital.

Recruiting
Registry status
NA
Development phase
85
Enrollment target
1
Study location

NCT06993688 is a NA study of Cancer and Communication that is actively recruiting participants, run by St. Jude Children's Research Hospital. The registered enrollment target is 85 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06993688, a NA study of Cancer and Communication, is actively recruiting participants, sponsored by St. Jude Children's Research Hospital.

RECRUITING
Registry status
NA
Development phase
85 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to obtain insights and feedback from patients and parents about a new approach to support conversations about how cancer may affect one's future life and quality of life (i.e., prognostic communication). This study involves creating a personalized approach to discussing prognosis. Primary Objectives * To evaluate the feasibility of implementing the RIGHTimeCPV intervention among pediatric oncology patients, caregivers, and clinicians (referred to herein as "shareholders"). * To assess the acceptability of the intervention across the shareholder groups. Secondary Objectives * To explore the potential impact of the RIGHTimeCPV intervention on communication quality, concordance in prognostic understanding, and therapeutic alliance between patients/families and multidisciplinary clinicians. * To explore whether the practice of eliciting, sharing, and honoring individualized communication preferences is sustained by clinicians after participation in the RIGHTimeCPV intervention.

Conditions Studied

Interventions

  • BEHAVIORAL Prognostic Communication-Patient/parent
  • BEHAVIORAL Prognostic Communication-CPC
  • BEHAVIORAL Prognostic Communication-Oncologist

Study Locations (1)

Tennessee

  • St. Jude Children's Research Hospital - Memphis

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2025-06-16
Est. Completion 2027-11-01
Phase NA

What the Registry Record Tells You About NCT06993688

The ClinicalTrials.gov registry entry for NCT06993688 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 3 interventions - of which Prognostic Communication-Patient/parent is the first listed.

NCT06993688 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT06993688 about?

NCT06993688 is a clinical study titled "Revealing Information Genuinely & Honestly Across Time - Communication Preferences Visit". The purpose of this research study is to obtain insights and feedback from patients and parents about a new approach to support conversations about how cancer may affect one's future life and quality of life (i.e., prognostic communication). This study involves creating a personalized approach to di...

What is the current status of trial NCT06993688?

This trial is currently recruiting. It is a NA study. The enrollment target is 85 participants. The study started on 2025-06-16. Estimated completion is 2027-11-01.

What conditions does trial NCT06993688 study?

This clinical trial studies the following conditions: Cancer, Communication.

What interventions are being tested in trial NCT06993688?

The interventions under investigation include: Prognostic Communication-Patient/parent (BEHAVIORAL), Prognostic Communication-CPC (BEHAVIORAL), Prognostic Communication-Oncologist (BEHAVIORAL).

Who is sponsoring clinical trial NCT06993688?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06993688 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.